New Study Suggests a Cancer Drug May Greatly Reduce Deaths in Hospitalized COVID Patients

The experimental drug sabizabulin, originally developed to treat cancer, significantly reduced the risk of acute respiratory distress syndrome (ARDS) and death in hospitalized patients with moderate to severe SARS-CoV-2 (COVID-19), according to a study...
Advertisement

Trending Stories

Focus on Transplantation

Hyperkalemia Management in Kidney Transplant Recipients

Extending Eligibility of Reinstatement of Waiting Time after Allograft Failure

The optimal treatment for kidney failure is kidney transplantation. The shortage of kidneys available for transplantation is intensifying, creating interest in the high proportion...
May/June Nephrology Times cover

Immunosuppression Adherence in Pediatric Kidney Transplant

Following solid-organ transplantation, the primary aim of care is preventing allosensitization. Despite potent immunosuppression, nonadherence often disrupts treatment, resulting in rejection. Among recipients of...
Doctor Consulting with patient

Fifty Years of Pediatric Kidney Transplantation: A Review

More than 13,000 pediatric kidney transplantations are performed worldwide each year. There have been dramatic changes in healthcare since the first pediatric transplantation in...

Access to Living Donor KT in Minority Communities

Racial disparities in living donor kidney transplantation are increasing. There are associations between living in linguistically isolated communities or in areas with large minority...
Greater Disability Tied to Worse COVID-19 Severity in MS Patients, Myocardial Injury Prevalent in Patients With Severe COVID-19

Solid Organ Transplants in Patients after COVID-19

Due to the continuing COVID-19 pandemic, it is important to determine the safety and timing of proceeding with solid organ transplantation in transplant candidates...